JP2008545725A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545725A5 JP2008545725A5 JP2008513997A JP2008513997A JP2008545725A5 JP 2008545725 A5 JP2008545725 A5 JP 2008545725A5 JP 2008513997 A JP2008513997 A JP 2008513997A JP 2008513997 A JP2008513997 A JP 2008513997A JP 2008545725 A5 JP2008545725 A5 JP 2008545725A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- disease
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0511060.6A GB0511060D0 (en) | 2005-05-31 | 2005-05-31 | Organic compounds |
| GB0511060.6 | 2005-05-31 | ||
| PCT/EP2006/005106 WO2006128658A1 (en) | 2005-05-31 | 2006-05-29 | Ergoline derivatives and their use as chemokine receptor ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008545725A JP2008545725A (ja) | 2008-12-18 |
| JP2008545725A5 true JP2008545725A5 (https=) | 2009-07-09 |
| JP5121703B2 JP5121703B2 (ja) | 2013-01-16 |
Family
ID=34834898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008513997A Expired - Fee Related JP5121703B2 (ja) | 2005-05-31 | 2006-05-29 | エルゴリン誘導体およびケモカイン受容体リガンドとしてのそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7666877B2 (https=) |
| EP (1) | EP1893611A1 (https=) |
| JP (1) | JP5121703B2 (https=) |
| KR (1) | KR20080013971A (https=) |
| CN (1) | CN101184754B (https=) |
| AU (1) | AU2006254395B2 (https=) |
| BR (1) | BRPI0611489A2 (https=) |
| CA (1) | CA2608702C (https=) |
| GB (1) | GB0511060D0 (https=) |
| MX (1) | MX2007015084A (https=) |
| RU (1) | RU2416613C2 (https=) |
| WO (1) | WO2006128658A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2012DN04858A (https=) * | 2009-12-23 | 2015-09-25 | Map Pharmaceuticals Inc | |
| US9095591B2 (en) | 2010-06-28 | 2015-08-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Pharmaceutical composition for use in the treatment of glaucoma |
| KR20140042868A (ko) | 2011-06-23 | 2014-04-07 | 맵 파마슈티컬스, 인코포레이티드 | 신규한 플루오로에르골린 유사체 |
| SG10201509139QA (en) | 2011-12-19 | 2015-12-30 | Map Pharmaceuticals Inc | Novel iso-ergoline derivatives |
| CA2859175A1 (en) | 2011-12-21 | 2013-06-27 | Map Pharmaceuticals, Inc. | Novel neuromodulatory compounds |
| RU2014153672A (ru) * | 2012-06-22 | 2016-08-10 | Мап Фармасьютикалс, Инк. | Новые каберголиновые производные |
| US9012640B2 (en) | 2012-06-22 | 2015-04-21 | Map Pharmaceuticals, Inc. | Cabergoline derivatives |
| MX2017009405A (es) | 2015-01-20 | 2018-01-18 | Xoc Pharmaceuticals Inc | Compuestos de tipo ergolina y usos de estos. |
| EP3247357A4 (en) | 2015-01-20 | 2018-07-11 | Xoc Pharmaceuticals, Inc | Isoergoline compounds and uses thereof |
| WO2018223065A1 (en) | 2017-06-01 | 2018-12-06 | Xoc Pharmaceuticals, Inc. | Ergoline derivatives for use in medicine |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| US12377112B2 (en) | 2019-04-17 | 2025-08-05 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
| EP4329759A4 (en) | 2021-04-30 | 2025-07-16 | Mind Medicine Inc | CRYSTALLINE FORMS OF LSD SALTS |
| US12611399B2 (en) | 2021-05-04 | 2026-04-28 | Definium Therapeutics US, Inc. | Movement disorders |
| JP7846211B2 (ja) | 2021-08-19 | 2026-04-14 | デフィニウム セラピューティクス ユーエス， インコーポレイテッド | 治療適用のためのｄ－リゼルグ酸ジエチルアミドの即時放出製剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000042071A2 (en) | 1999-01-12 | 2000-07-20 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
| EP2070921A1 (en) | 2000-11-07 | 2009-06-17 | Novartis Ag | Indolylmaleimide derivatives as protein kinase c inhibitors |
| TW200918046A (en) | 2002-04-03 | 2009-05-01 | Novartis Ag | Indolylmaleimide derivatives |
-
2005
- 2005-05-31 GB GBGB0511060.6A patent/GB0511060D0/en not_active Ceased
-
2006
- 2006-05-29 MX MX2007015084A patent/MX2007015084A/es active IP Right Grant
- 2006-05-29 KR KR1020077027902A patent/KR20080013971A/ko not_active Withdrawn
- 2006-05-29 CA CA2608702A patent/CA2608702C/en not_active Expired - Fee Related
- 2006-05-29 US US11/914,570 patent/US7666877B2/en not_active Expired - Fee Related
- 2006-05-29 JP JP2008513997A patent/JP5121703B2/ja not_active Expired - Fee Related
- 2006-05-29 AU AU2006254395A patent/AU2006254395B2/en not_active Ceased
- 2006-05-29 EP EP06753946A patent/EP1893611A1/en not_active Withdrawn
- 2006-05-29 BR BRPI0611489-0A patent/BRPI0611489A2/pt not_active IP Right Cessation
- 2006-05-29 CN CN2006800186451A patent/CN101184754B/zh not_active Expired - Fee Related
- 2006-05-29 RU RU2007147597/04A patent/RU2416613C2/ru not_active IP Right Cessation
- 2006-05-29 WO PCT/EP2006/005106 patent/WO2006128658A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008545725A5 (https=) | ||
| JP2012504133A5 (https=) | ||
| JP2011505356A5 (https=) | ||
| JP2018518537A5 (https=) | ||
| JP2008195730A5 (https=) | ||
| JP2005508967A5 (https=) | ||
| JP2011509259A5 (https=) | ||
| JP2007145875A5 (https=) | ||
| JP2013515472A5 (https=) | ||
| JP2012041365A5 (https=) | ||
| JP2008513498A5 (https=) | ||
| HRP20140807T1 (hr) | Derivati pirolo[2,3-d]pirimidina kao inhibitori protein kinaze b | |
| CA2516370A1 (en) | A process of preparing imatinib and imatinib prepared thereby | |
| JP2004534850A5 (https=) | ||
| CA2409741A1 (en) | Tnf-.alpha. production inhibitors | |
| JP2009514837A5 (https=) | ||
| JP2009510064A5 (https=) | ||
| JP2020533352A5 (https=) | ||
| JP2009514835A5 (https=) | ||
| JP2013542261A5 (https=) | ||
| RU2007130144A (ru) | Гетероциклические соединения в качестве антагонистов cccr2b | |
| JP2012513390A5 (https=) | ||
| JP2007515476A5 (https=) | ||
| JP2008513510A5 (https=) | ||
| JP2009511450A5 (https=) |